We are live on ! Find out more
Osaic Holdings

Osaic Holdings Portfolio holdings

AUM $68.3B
1-Year Est. Return 20.5%
This Fund
S&P 500
This Quarter Est. Return
+7.61%
1 Year Est. Return
+20.5%
3 Year Est. Return
+61.22%
5 Year Est. Return
+69.4%
10 Year Est. Return
AUM
$49.4B
AUM Growth
+$5.63B
Cap. Flow
+$2.84B
Cap. Flow %
5.75%
Top 10 Hldgs %
14.48%
Holding
7,819
New
272
Increased
3,594
Reduced
2,623
Closed
373

Sector Composition

Rank Sector Weight
1 Technology 7.49%
2 Financials 4.57%
3 Healthcare 4.43%
4 Industrials 3.25%
5 Consumer Discretionary 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVIR icon
5576
Atea Pharmaceuticals
AVIR
$420M
$19K ﹤0.01%
3,771
-421
-10% -$2.13K
CAPR icon
5577
Capricor Therapeutics
CAPR
$237M
$19K ﹤0.01%
5,000
GINN icon
5578
Goldman Sachs Innovate Equity ETF
GINN
$213M
$19K ﹤0.01%
475
-7
-1% -$288
HSTM icon
5579
HealthStream
HSTM
$840M
$19K ﹤0.01%
787
-12
-2% -$288
HTOO icon
5580
Fusion Fuel Green
HTOO
$17.1M
$19K ﹤0.01%
121
-30
-20% -$4.71K
HY icon
5581
Hyster-Yale Materials Handling
HY
$665M
$19K ﹤0.01%
746
-51
-6% -$1.42K
MRSN
5582
DELISTED
Mersana Therapeutics
MRSN
$19K ﹤0.01%
129
NERD icon
5583
Roundhill Video Games ETF
NERD
$15.7M
$19K ﹤0.01%
1,388
-28
-2% -$393
OXSQ icon
5584
Oxford Square Capital
OXSQ
$157M
$19K ﹤0.01%
6,054
-2,944
-33% -$8.97K
TALO icon
5585
Talos Energy
TALO
$2.4B
$19K ﹤0.01%
1,037
+267
+35% +$5.36K
TMQ
5586
Trilogy Metals
TMQ
$656M
$19K ﹤0.01%
34,961
TRX icon
5587
TRX Gold Corp
TRX
$344M
$19K ﹤0.01%
58,678
UAE icon
5588
iShares MSCI UAE ETF
UAE
$322M
$19K ﹤0.01%
1,258
-4,283
-77% -$66K
UTMD icon
5589
Utah Medical Products
UTMD
$225M
$19K ﹤0.01%
187
VALN
5590
Valneva
VALN
$541M
$19K ﹤0.01%
1,450
VYGR icon
5591
Voyager Therapeutics
VYGR
$201M
$19K ﹤0.01%
3,100
+600
+24% +$3.41K
NVEI
5592
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
$19K ﹤0.01%
750
+560
+295% +$15.9K
RNLX
5593
DELISTED
Renalytix plc American Depositary Shares
RNLX
$19K ﹤0.01%
10,022
-2,284
-19% -$3.57K
ONCT
5594
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$19K ﹤0.01%
980
-49
-5% -$975
LTHM
5595
CALL
DELISTED
Livent Corporation
LTHM
$19K ﹤0.01%
+17
New +$465
PNT
5596
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$19K ﹤0.01%
2,670
KKR.PRC
5597
DELISTED
KKR & Co. Inc. 6.00% Series C Mandatory Convertible Preferred Stock
KKR.PRC
$19K ﹤0.01%
331
-373
-53% -$22.5K
ATCX
5598
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$19K ﹤0.01%
3,694
+1,150
+45% +$7.17K
PLM
5599
DELISTED
PolyMet Mining Corp.
PLM
$19K ﹤0.01%
7,296
-305
-4% -$878
JMM icon
5600
Nuveen Multi-Market Income Fund
JMM
$54.7M
$18.6K ﹤0.01%
3,095
+1,800
+139% +$10.4K

Similar funds

Osaic Holdings's Q4 2022 Portfolio in Review

As of Q4 2022, Osaic Holdings held 7,819 positions worth $49.4B, up 13% from $43.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Osaic Holdings deployed $2.84B of net new capital in Q4 2022, opening 272 new positions and adding to 3,594 existing holdings. Its largest new stake was AB Ultra Short Income ETF: 328,874 shares worth $16.4M.

By sector, the portfolio is most concentrated in Technology at 7.5% of assets, down from 7.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $399M trimmed.

  • Osaic Holdings's largest Q4 2022 buy was AB Ultra Short Income ETF: 328,874 shares worth $16.4M.
  • Osaic Holdings added most to State Street SPDR Portfolio S&P 500 Value ETF in Q4 2022, an estimated $392M increase.
  • Osaic Holdings's biggest Q4 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $399M.
  • Osaic Holdings fully exited Invesco BulletShares 2022 Corporate Bond ETF in Q4 2022, selling an estimated $8.94M.
  • Osaic Holdings's ten largest holdings make up 14% of its $49.4B portfolio in Q4 2022.
  • Osaic Holdings opened 272 new positions and closed 373 in Q4 2022.
  • Osaic Holdings's portfolio value rose 13% quarter-over-quarter to $49.4B.

Based on Osaic Holdings's 13F filing for Q4 2022, filed 10 Feb 2023.